THE EFFECTS OF AGE AND GENDER ON THE STEREOSELECTIVE PHARMACOKINETICS OF VERAPAMIL

被引:35
作者
SASAKI, M [1 ]
TATEISHI, T [1 ]
EBIHARA, A [1 ]
机构
[1] JICHI MED SCH, DEPT CLIN PHARMACOL & THERAPEUT, MINAMI KAWACHI, TOCHIGI 32904, JAPAN
关键词
D O I
10.1038/clpt.1993.148
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The effects of age and gender on the pharmacokinetics of verapamil stereoisomers were examined. Eighty milligrams of racemic verapamil was given orally to 12 young and 12 elderly healthy subjects, half of whom were women. The area under the plasma concentration-time curves (AUC) of (S)- and (R)-verapamil were greater in the elderly group than in the young group [(S)-/(R)-verapamil (mean +/-SD), 214.4 +/- 123.0/1582.2 +/- 763.0 and 50.4 +/- 36.5/584.9 +/- 252.4 ng . hr/ml for the elderly and young groups, respectively (p < 0.001/p < 0.001)]. Conversely, the apparent oral clearance values of (S)-and (R) -verapamil were significantly smaller in the elderly group than in the young group [(S)-/(R)-verapamil (mean +/- SD), 4.8 +/- 3.0/0.53 +/- 0.21 and 22.5 +/- 21.3/1.30 +/- 0.67 L/hr/kg for the elderly and young groups, respectively (p < 0.01/p < 0.001)]. The ratio of apparent oral clearance of (S)- to (R)-verapamil was significantly smaller in the elderly group than in the young group. As a consequence, the negative chronotropic and dromotropic effect of verapamil was observed in the elderly group. This study suggests that the effect of age on metabolism was greater for (S)-verapamil than for (R)-verapamil.
引用
收藏
页码:278 / 285
页数:8
相关论文
共 22 条
[1]   VERAPAMIL PHARMACODYNAMICS AND DISPOSITION IN YOUNG AND ELDERLY HYPERTENSIVE PATIENTS - ALTERED ELECTROCARDIOGRAPHIC AND HYPOTENSIVE RESPONSES [J].
ABERNETHY, DR ;
SCHWARTZ, JB ;
TODD, EL ;
LUCHI, R ;
SNOW, E .
ANNALS OF INTERNAL MEDICINE, 1986, 105 (03) :329-336
[2]   EFFECT OF AGING ON THE HEPATIC CLEARANCE OF PROPRANOLOL [J].
CASTLEDEN, CM ;
GEORGE, CF .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1979, 7 (01) :49-54
[3]   AGE-ASSOCIATED STEREOSELECTIVE ALTERATIONS IN HEXOBARBITAL METABOLISM [J].
CHANDLER, MHH ;
SCOTT, SR ;
BLOUIN, RA .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1988, 43 (04) :436-441
[4]   PROTEIN-BINDING AND DISPOSITION OF LIGNOCAINE IN THE ELDERLY [J].
CUSACK, B ;
OMALLEY, K ;
LAVAN, J ;
NOEL, J ;
KELLY, JG .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1985, 29 (03) :323-329
[5]   ELECTROPHYSIOLOGIC EFFECTS OF DEXTRO-VERAPAMIL AND LEVO-VERAPAMIL ON SINUS NODE AND AV NODE FUNCTION IN HUMANS [J].
ECHIZEN, H ;
MANZ, M ;
EICHELBAUM, M .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1988, 12 (05) :543-546
[6]   PHARMACOKINETICS OF (+)-VERAPAMIL, (-)-VERAPAMIL AND (+/-)-VERAPAMIL AFTER INTRAVENOUS ADMINISTRATION [J].
EICHELBAUM, M ;
MIKUS, G ;
VOGELGESANG, B .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1984, 17 (04) :453-458
[7]   INTER-SUBJECT AND INTRA-SUBJECT VARIATION IN THE 1ST-PASS ELIMINATION OF HIGHLY CLEARED DRUGS DURING CHRONIC DOSING - STUDIES WITH DEUTERATED VERAPAMIL [J].
EICHELBAUM, M ;
SOMOGYI, A .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1984, 26 (01) :47-53
[8]  
EICHELBAUM M, 1979, DRUG METAB DISPOS, V7, P145
[9]  
GREENBLATT DJ, 1982, NEW ENGL J MED, V306, P1081
[10]  
GRENCHBELANGER O, 1989, J CLIN PHARMACOL, V29, P311